CONMED Corporation
CONMED Corporation (CNMD) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cnmd · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for CONMED Corporation (CNMD) measures how much investors pay for each dollar of the company's trailing earnings. CNMD's current PE ratio of 19.61x is calculated by dividing its stock price of $35.16 by its TTM earnings per share of $1.79. −80.3% discount vs 5Y avg 99.5x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 18 fiscal years · Front-end computedMinQ1 · 25%39.1x
MedianQ3 · 75%964.2x
Max
At 19.61x, CNMD's current P/E is lower than in 22% of its annual fiscal year readings over the past 18 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
CONMED CorporationYou CNMD | $1.1B | 19.61x | — | $1.79 |
 AdaptHealth Corp. AHCO | $1.3B | N/A | — | -$0.52 |
 Azenta, Inc. AZTA | $1.0B | N/A | — | -$1.22 |
 Establishment Labs Holdings Inc. ESTA | $2.2B | N/A | — | -$1.72 |
 InMode Ltd. INMD | $823M | 10.12x | — | $1.45 |
 Kestra Medical Technologies, Ltd. KMTS | $1.1B | N/A | — | -$2.30 |
 Neogen Corporation NEOG | $1.9B | N/A | — | -$5.03 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 26.78x | $1.52 | +68.0% | |
2024-12-31 FY2024 | 15.94x | $4.29 | -69.4% | |
2023-12-31 FY2023 | 52.10x | $2.10 | — | |
2022-12-31 FY2022 | — | $-2.68 | — | |
2021-12-31 FY2021 | 66.10x | $2.14 | -80.3% | |
2020-12-31 FY2020 | 336.35x | $0.33 | +203.9% | |
2019-12-31 FY2019 | 110.68x | $1.01 | +150.5% | |
2018-12-31 FY2018 | 44.19x | $1.45 | +72.2% | |
2017-12-31 FY2017 | 25.66x | $1.99 | -69.4% | |
2016-12-31 FY2016 | 83.75x | $0.53 | +109.7% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for CONMED Corporation (CNMD) measures how much investors pay for each dollar of the company's trailing earnings. CNMD's current PE ratio of 19.61x is calculated by dividing its stock price of $35.16 by its TTM earnings per share of $1.79.
Frequently asked questions
CNMD pe ratio · 6 questionsCNMD's current PE ratio is 19.61x as of 2026-06-08, based on a stock price of $35.16 and TTM EPS of $1.79. Data sourced from Financial Modeling Prep via CNMD's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CONMED Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08